The Clinically Used Iron Chelator Deferasirox Is an Inhibitor of Epigenetic JumonjiC Domain-Containing Histone Demethylases. (2019)
Attributed to:
RapidFire Enhancement of Mass Spectrometry Capability Across the Biosciences
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1021/acschembio.9b00289
PubMed Identifier: 31287655
Publication URI: http://europepmc.org/abstract/MED/31287655
Type: Journal Article/Review
Volume: 14
Parent Publication: ACS chemical biology
Issue: 8
ISSN: 1554-8929